My Size, Inc. filings document the public-company reporting record for a Nasdaq-listed fashion technology and commerce issuer. The company’s Form 8-K filings report operating results, preliminary financial information, Regulation FD communications, shareholder letters and Nasdaq listing-compliance notices related to its common stock.
Proxy and annual-meeting filings cover board elections, equity incentive plan amendments, share-reserve provisions, auditor ratification and stockholder voting results. The filing record also includes late-filing notices for periodic reports, together with exhibits and Inline XBRL cover-page data that support the company’s formal disclosure of results, governance matters, capital structure and reporting status.
My Size, Inc. (MYSZ) filed a shelf registration statement covering potential offerings of up to $100,000,000 in aggregate initial offering price across common stock, debt securities, warrants and units. The company may conduct one or more offerings after the registration statement becomes effective; specific terms will be provided in the applicable prospectus supplement.
My Size currently intends to use net proceeds for working capital, repayment of trade payables and general corporate purposes. It also announced an acquisition-led growth strategy focused on evaluating potential acquisitions to build a defense technology platform, diversifying beyond its fashion technology and commerce operations.
My Size, Inc. approved the removal of Chief Growth Officer Borja Cembrero Saralegui effective October 31, 2026. Its subsidiary, Naiz Bespoke Technologies, S.L., separately removed him as Executive Director effective that date. The company said the removal was not due to a disagreement over its operations, policies or practices.
Under a separation agreement, My Size and Naiz jointly and severally acknowledged €433,150.68 payable to Cembrero, including €228,493.15 in severance, €18,904.11 in lieu of notice, €5,753.42 in unused vacation pay and €180,000 for a two-year non-competition covenant. €125,000 is scheduled in cash installments from November 2026 through August 2027. The parties will negotiate a plan for the remaining €308,150.68, which may be paid in cash, in kind or a combination, including through a transfer of equity interests in a group entity. Without an agreed plan, that balance is due August 18, 2027. Overdue amounts accrue Spanish statutory interest, and a payment default accelerates all outstanding amounts. The agreement contains no release of claims; a final settlement is to follow payment in full.
My Size, Inc. disclosed that Stephen Arthur Eckinger acquired 69,600 shares on October 13, 2026, representing approximately 7.93% of the 878,036 shares outstanding. He disposed of 28,100 shares on the same date and then beneficially owned 41,500 shares, or 4.73%.
My Size, Inc. (MYSZ) registered for resale up to 4,018,326 shares of common stock issuable upon exercise of warrants held by selling stockholders. My Size receives no proceeds from resales, but may receive proceeds if holders exercise warrants for cash.
The related private placement closed September 16, 2026, generating approximately $2.5 million in gross proceeds before fees and expenses. Pre-funded warrants are immediately exercisable at $0.001 per share and do not expire until exercised in full; Series C and D warrants are immediately exercisable at $1.66 per share, with five-year and 18-month terms, respectively, from the resale registration statement’s effective date. If all Private Placement Warrants and Placement Agent Warrants were exercised for cash in full, proceeds would be approximately $4.57 million; My Size intends to use any net proceeds for general corporate purposes and working capital.
On September 14, 2026, My Size announced an acquisition-led strategy to evaluate potential defense-technology acquisitions, subject to suitable targets, due diligence, definitive agreements, financing and required approvals. Its 2025 audit report states that significant losses, negative operating cash flows and accumulated deficit raise substantial doubt about its ability to continue as a going concern.
My Size, Inc. (MYSZ) registers for resale up to 4,018,326 shares of common stock issuable upon warrant exercise; selling stockholders may not sell until the registration statement is effective. My Size will receive no proceeds from resale sales, but may receive proceeds from cash warrant exercises; if all referenced warrants are exercised for cash in full, proceeds would be approximately $4.57 million. Net proceeds from any such exercises are intended for general corporate purposes and working capital. The private placement closed September 16, 2026, with approximately $2.5 million in gross proceeds.
On September 14, 2026, the company announced an acquisition-led strategy to evaluate and potentially acquire defense technology businesses, subject to suitable targets, due diligence, definitive agreements, financing and required approvals. The audit report on its 2025 financial statements cites significant losses, negative operating cash flows and an accumulated deficit that raise substantial doubt about its ability to continue as a going concern.
My Size, Inc. (MYSZ) completed a private exempt offering of equity-linked securities under Regulation D, claiming the Rule 506(b) exemption. The company sold securities for $2,498,692, consisting of 1,308,901 pre-funded warrants, 1,308,901 Series C warrants and 1,308,901 Series D warrants at a combined purchase price of $1.91 per pre-funded warrant and accompanying series warrants.
The issuer states that net proceeds are intended for general corporate purposes, including working capital. H.C. Wainwright & Co., LLC received a management fee equal to 1.0% of the offering proceeds, $50,000 for accountable expenses, $35,000 for non-accountable expenses and 91,623 unregistered warrants to purchase common stock. The date of first sale was September 15, 2026.
My Size, Inc. (MYSZ) entered into a securities purchase agreement for a private placement of up to 1,308,901 unregistered pre-funded warrants together with Series C and Series D warrants, at an offering price of $1.91 per pre-funded warrant and associated Series Warrants, for aggregate gross proceeds of approximately $2.5 million. The pre-funded warrants are immediately exercisable at $0.001 per share and remain outstanding until fully exercised, while the Series C and Series D warrants are immediately exercisable at $1.66 per share, with five-year and 18‑month terms, respectively, starting from the effective date of a resale registration statement. H.C. Wainwright & Co. is acting as exclusive placement agent and will receive cash fees, expense reimbursements, and 91,623 placement agent warrants; the company has agreed to file a resale registration statement within 15 days and obtain effectiveness within specified SEC review timelines, and the offering is expected to close on or about September 16, 2026, subject to customary conditions.
My Size, Inc. (MYSZ) reported that Nasdaq has notified the company it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000 for continued listing on the Nasdaq Capital Market. My Size reported $2,347,000 of stockholders’ equity as of June 30, 2026 in its Form 10‑Q.
The notice does not immediately affect the trading of My Size’s common stock on Nasdaq. The company has 45 days, until October 9, 2026, to submit a compliance plan. If Nasdaq accepts the plan, My Size may receive up to 180 days from August 25, 2026, through February 21, 2027, to regain compliance. If My Size cannot regain compliance, Nasdaq staff would issue a delisting determination, which the company could appeal to a Nasdaq Hearings Panel, temporarily staying any delisting action.
MySize, Inc. reported strong top-line growth but weaker profitability for the quarter and six months ended June 30, 2026. Second-quarter revenue rose 53% year-over-year to $3.07 million, and first-half revenue grew 57% to $5.46 million, driven by expansion in fashion e-commerce, the Percentil resale platform and contributions from Ten Peacks.
Despite this growth, profitability deteriorated. Quarterly gross profit was $973,000 and gross margin fell to 31.7% from 56.0%, reflecting a revenue mix shift toward lower-margin commerce activities. Operating loss widened to $1.72 million and net loss to $1.75 million for the quarter; first-half net loss was $3.13 million. Operating expenses increased across R&D, sales and marketing, and G&A as the platform scaled.
The SaaS Solutions segment remained highly profitable, generating 86% gross margin on $211,000 of revenue, and net cash used in operating activities for the first half improved to $1.97 million from $2.31 million. As of June 30, 2026, MySize held $453,000 in cash and cash equivalents and $258,000 in restricted cash, and disclosed that it expects continued losses and negative operating cash flows and will require additional capital to support its operations and growth strategy.